Evaluating the Inhibitory Effects of Colchicine and Propranolol on Toxoplasma gondii Entrance into Host Cells in vitro and in vivo

A. Daryani, M. Ebrahimzadeh, A. Pagheh, M. Sharif, S. Sarvi, E. Ahmadpour, S. Aghayan, F. Rezaei
{"title":"Evaluating the Inhibitory Effects of Colchicine and Propranolol on Toxoplasma gondii Entrance into Host Cells in vitro and in vivo","authors":"A. Daryani, M. Ebrahimzadeh, A. Pagheh, M. Sharif, S. Sarvi, E. Ahmadpour, S. Aghayan, F. Rezaei","doi":"10.52547/iem.8.3.251","DOIUrl":null,"url":null,"abstract":"Article Type Original Article Authors Ahmad Daryani, PhD1 Mohammad Ali Ebrahimzadeh, PhD2 Abdol Sattar Pagheh, PhD3 Mahdi Sharif, PhD1 Shahabeddin Sarvi, PhD1 Ehsan Ahmadpour, PhD4 Sargis Aghayan, PhD5 Fatemeh Rezaei, PhD6* How to cite this article Daryani A., Ebrahimzadeh MA., Pagheh AS., Sharif M., Sarvi SH., Ahmadpour E., Aghayan S., Rezaei F. Evaluating the Inhibitory Effects of Colchicine and Propranolol on Toxoplasma gondii Entrance into Host Cells in vitro and in vivo. Infection Epidemiology and Microbiology. 2022;8(3): 251-258 1 Toxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran 2 Pharmaceutical Sciences Research Center, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran 3 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran 4 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran 5 Laboratory of Zoology, Research Institute of Biology, Yerevan State University, Yerevan, Republic of Armenia. 6 Islamic Azad University of Chalous Branch, Chalous, Iran * Correspondence Islamic Azad University of Chalous Branch, Chalous, Iran, PC 4816895475, Sari, Iran. Email: rezaei63@iauc.ac.ir Article History Received: February 07 ,2022 Accepted: July 20 ,2022 Published: September 19 ,2022 Backgrounds: Toxoplasma gondii is a zoonotic parasite of increasing concern to humans and animals. Considering the side effects of drugs used to treat toxoplasmosis, it is essential to find alternative drugs. Materials & Methods: In this study, colchicine and propranolol at four concentrations (1, 5, 10, and 15 μg/mL) were added to the RPMI medium containing peritoneal macrophages and incubated for 60 min, Then tachyzoites were added to the medium, and the efficacy rates of colchicine and propranolol in inhibiting tachyzoites entry into macrophages were evaluated after 30 and 60 min. For in vivo assay, one group received no drugs, and the second group was treated with colchicine and propranolol at different concentrations for different durations. Findings: The in vitro experiment showed that treatment with 15 mg/mL of colchicine and propranolol for 60 min following tachyzoites addition was the most efficient method to inhibit tachyzoites penetration, indicating the efficacy rates of 80.20%±1.20 and 89.97%±1.30, respectively (p< .05). Based on the in vivo test, pretreatment with 2 mg/kg of colchicine one hour before tachyzoites injection had the best inhibitory effect (70.32%±4.07). Also, pretreatment with 2 mg/kg of propranolol 90 min before tachyzoites injection (78.54%±1.99) induced the best inhibitory effect (p< .05). Conclusion: According to the results, colchicine and propranolol could inhibit tachyzoites entrance into nucleated cells in vitro and in vivo. In this study, the most efficient concentrations and times for using these substances were determined. Copyright@ 2022, TMU Press. This open-access article is published under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License which permits Share (copy and redistribute the material in any medium or format) and Adapt (remix, transform, and build upon the material) under the Attribution-NonCommercial terms. 10.52547/iem.8.3.251","PeriodicalId":34545,"journal":{"name":"Infection Epidemiology and Microbiology","volume":"51 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection Epidemiology and Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52547/iem.8.3.251","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Article Type Original Article Authors Ahmad Daryani, PhD1 Mohammad Ali Ebrahimzadeh, PhD2 Abdol Sattar Pagheh, PhD3 Mahdi Sharif, PhD1 Shahabeddin Sarvi, PhD1 Ehsan Ahmadpour, PhD4 Sargis Aghayan, PhD5 Fatemeh Rezaei, PhD6* How to cite this article Daryani A., Ebrahimzadeh MA., Pagheh AS., Sharif M., Sarvi SH., Ahmadpour E., Aghayan S., Rezaei F. Evaluating the Inhibitory Effects of Colchicine and Propranolol on Toxoplasma gondii Entrance into Host Cells in vitro and in vivo. Infection Epidemiology and Microbiology. 2022;8(3): 251-258 1 Toxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran 2 Pharmaceutical Sciences Research Center, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran 3 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran 4 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran 5 Laboratory of Zoology, Research Institute of Biology, Yerevan State University, Yerevan, Republic of Armenia. 6 Islamic Azad University of Chalous Branch, Chalous, Iran * Correspondence Islamic Azad University of Chalous Branch, Chalous, Iran, PC 4816895475, Sari, Iran. Email: rezaei63@iauc.ac.ir Article History Received: February 07 ,2022 Accepted: July 20 ,2022 Published: September 19 ,2022 Backgrounds: Toxoplasma gondii is a zoonotic parasite of increasing concern to humans and animals. Considering the side effects of drugs used to treat toxoplasmosis, it is essential to find alternative drugs. Materials & Methods: In this study, colchicine and propranolol at four concentrations (1, 5, 10, and 15 μg/mL) were added to the RPMI medium containing peritoneal macrophages and incubated for 60 min, Then tachyzoites were added to the medium, and the efficacy rates of colchicine and propranolol in inhibiting tachyzoites entry into macrophages were evaluated after 30 and 60 min. For in vivo assay, one group received no drugs, and the second group was treated with colchicine and propranolol at different concentrations for different durations. Findings: The in vitro experiment showed that treatment with 15 mg/mL of colchicine and propranolol for 60 min following tachyzoites addition was the most efficient method to inhibit tachyzoites penetration, indicating the efficacy rates of 80.20%±1.20 and 89.97%±1.30, respectively (p< .05). Based on the in vivo test, pretreatment with 2 mg/kg of colchicine one hour before tachyzoites injection had the best inhibitory effect (70.32%±4.07). Also, pretreatment with 2 mg/kg of propranolol 90 min before tachyzoites injection (78.54%±1.99) induced the best inhibitory effect (p< .05). Conclusion: According to the results, colchicine and propranolol could inhibit tachyzoites entrance into nucleated cells in vitro and in vivo. In this study, the most efficient concentrations and times for using these substances were determined. Copyright@ 2022, TMU Press. This open-access article is published under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License which permits Share (copy and redistribute the material in any medium or format) and Adapt (remix, transform, and build upon the material) under the Attribution-NonCommercial terms. 10.52547/iem.8.3.251
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
秋水仙碱和心得安对刚地弓形虫体内外侵入宿主细胞抑制作用的研究
文章类型原创作者Ahmad Daryani, phd Mohammad Ali Ebrahimzadeh, phd Abdol Sattar Pagheh, phd Mahdi Sharif, phd Shahabeddin Sarvi, phd Ehsan Ahmadpour, phd Sargis Aghayan, phd Fatemeh Rezaei, PhD6*如何引用本文Daryani A., Ebrahimzadeh MAPagheh AS。[3],李建平,李建平,李建平,等。秋水仙碱和心得安对刚地弓形虫的体外和体内抑制作用。感染流行病学与微生物学,2022;8(3):1伊朗萨里马赞达兰医科大学弓形虫病研究中心2伊朗萨里马赞达兰医科大学药学院药学科学研究中心3伊朗伯尔詹医科大学传染病研究中心4伊朗大不里士医科大学药物应用研究中心5埃里温州立大学生物研究所动物实验室,埃里温,6伊斯兰阿扎德大学查卢斯分校,伊朗查卢斯*通信伊斯兰阿扎德大学查卢斯分校,伊朗萨里PC 4816895475Email: rezaei63@iauc.ac.ir文章历史收稿日期:2022年2月07日接收日期:2022年7月20日发布日期:2022年9月19日背景:刚地弓形虫是一种日益受到人类和动物关注的人畜共患寄生虫。考虑到用于治疗弓形虫病的药物的副作用,寻找替代药物至关重要。材料与方法:本研究将4种浓度(1、5、10、15 μg/mL)的秋水仙碱和心得安分别加入到含有腹膜巨噬细胞的RPMI培养基中,孵育60 min,然后在培养基中加入速殖子,分别于30、60 min后观察秋水仙碱和心得安抑制速殖子进入巨噬细胞的效果。第二组给予秋水仙碱和心得安不同浓度的治疗,治疗时间不同。结果:体外实验显示,添加速殖子后,以15 mg/mL秋水仙碱加心得安处理60 min对速殖子渗透的抑制效果最好,其有效率分别为80.20%±1.20和89.97%±1.30 (p< 0.05)。体内实验结果表明,注射速殖子前1 h用2 mg/kg秋水仙碱预处理效果最佳(70.32%±4.07)。注射速殖子前90 min预处理2 mg/kg心得安(78.54%±1.99),抑制效果最佳(p< 0.05)。结论:秋水仙碱和心得安在体外和体内均能抑制速殖子进入有核细胞。在本研究中,确定了这些物质的最有效浓度和使用时间。版权所有:TMU出版社。这篇开放获取的文章是在知识共享署名-非商业4.0国际许可证的条款下发布的,该许可证允许在署名-非商业条款下共享(以任何媒介或格式复制和再分发材料)和改编(重新混合,转换和构建材料)。10.52547 / iem.8.3.251
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
20
审稿时长
6 weeks
期刊最新文献
Tracing the Origin and Early Progression of COVID-19 in Europe: An Epidemiological Descriptive Study Exploring Antibiotic Susceptibility in Otomycosis: Uncovering Mixed Infections of Fungal and Bacterial Origin in Indonesia Antimicrobial Activity of Traditional Medicinal Plant Extracts against Bacterial and Fungal Strains Causing Dental Caries: An in Vitro Study Prevalence of Extended-Spectrum B-Lactamase (ESBL) and Quinolone Resistance (qnr) Genes among Cytotoxic Necrotizing Factor-1-Producing Uropathogenic Escherichia coli in Babylon, Iraq Association between Torque Teno Virus Frequency and Systemic Lupus Erythematosus: A Potential Trigger for Autoimmune Diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1